Table 1 from Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid Tumors
收藏数据链接：
官方服务：
资源简介：
Patient disposition
创建时间：
2025-03-10
社区交流群
科研交流群
商业服务
Patient disposition